Utilized for epilepsy and trigeminal neuralgia to manage electrical stability and support neurological comfort.
Mechanism of Action
Carbamazepine stabilizes hyperexcited nerve membranes by blocking voltage-gated sodium channels. This inhibits repetitive neuronal firing and reduces the synaptic propagation of excitatory impulses.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
12–24 hours
Contraindications
Bone marrow suppression, Concurrent use of MAO inhibitors, Hypersensitivity to tricyclic antidepressants
Severe Adverse Events
Aplastic anemia, Stevens-johnson syndrome, Hepatotoxicity — requires immediate medical attention
Information related to Carbamazepine is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
